Oklo Inc. (NYSE:OKLO – Get Free Report) General Counsel Vivek Narayanadas sold 364 shares of the firm’s stock in a transaction on Friday, October 9th. The shares were sold at an average price of $34.69, for a total value of $12,627.16. Following the sale, the general counsel directly owned 8,769 shares in the company, valued at approximately $304,196.61. This trade represents a 3.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Vivek Narayanadas also recently made the following trade(s):
- On Tuesday, October 6th, Vivek Narayanadas sold 288 shares of Oklo stock. The stock was sold at an average price of $37.29, for a total value of $10,739.52.
- On Monday, October 5th, Vivek Narayanadas sold 649 shares of Oklo stock. The stock was sold at an average price of $35.93, for a total value of $23,318.57.
- On Wednesday, September 9th, Vivek Narayanadas sold 365 shares of Oklo stock. The shares were sold at an average price of $43.31, for a total value of $15,808.15.
- On Tuesday, September 8th, Vivek Narayanadas sold 238 shares of Oklo stock. The shares were sold at an average price of $42.06, for a total value of $10,010.28.
- On Friday, September 4th, Vivek Narayanadas sold 538 shares of Oklo stock. The stock was sold at an average price of $39.88, for a total value of $21,455.44.
- On Tuesday, August 25th, Vivek Narayanadas sold 223 shares of Oklo stock. The shares were sold at an average price of $40.80, for a total value of $9,098.40.
- On Monday, August 24th, Vivek Narayanadas sold 3,264 shares of Oklo stock. The stock was sold at an average price of $39.77, for a total transaction of $129,809.28.
Oklo Stock Down 1.2%
NYSE OKLO traded down $0.39 on Tuesday, hitting $31.82. The company’s stock had a trading volume of 8,868,710 shares, compared to its average volume of 11,185,156. The company’s 50-day moving average is $40.11 and its 200 day moving average is $51.01. The firm has a market cap of $5.92 billion, a PE ratio of -33.85 and a beta of 1.20. Oklo Inc. has a 1-year low of $31.02 and a 1-year high of $193.84.
Hedge Funds Weigh In On Oklo
Hedge funds have recently bought and sold shares of the company. Citizens Financial Group Inc. RI boosted its position in Oklo by 1.0% during the first quarter. Citizens Financial Group Inc. RI now owns 18,704 shares of the company’s stock valued at $928,000 after acquiring an additional 182 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in Oklo by 0.3% during the 1st quarter. The Manufacturers Life Insurance Company now owns 70,433 shares of the company’s stock worth $3,493,000 after acquiring an additional 183 shares during the period. Triton Wealth Management PLLC grew its holdings in Oklo by 1.3% during the 1st quarter. Triton Wealth Management PLLC now owns 14,760 shares of the company’s stock worth $734,000 after acquiring an additional 191 shares during the period. Costello Asset Management INC grew its holdings in Oklo by 66.7% during the 1st quarter. Costello Asset Management INC now owns 500 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the period. Finally, Swedbank AB raised its position in shares of Oklo by 3.4% in the 1st quarter. Swedbank AB now owns 10,592 shares of the company’s stock worth $525,000 after acquiring an additional 345 shares in the last quarter. Institutional investors own 85.03% of the company’s stock.
Key Oklo News
Here are the key news stories impacting Oklo this week:
- Positive Sentiment: Oklo announced that it will advance its Groves 2 Forge isotope-production facility through the U.S. Department of Energy’s National Reactor Innovation Center Nuclear Energy Launch Pad initiative. The project builds on the Groves Isotope Test Reactor and could support future production of medical and other high-value isotopes. Oklo to Advance Groves 2 Forge as Part of U.S. Department of Energy’s Nuclear Energy Launch Pad Selection
- Positive Sentiment: The isotope strategy gives Oklo a potential business beyond electricity generation. Progress on reactor milestones, critical-material procurement and laboratory capabilities may expand its long-term revenue opportunities, while the company’s reported 20-year power purchase agreements with Meta provide additional commercial visibility. OKLO Builds on Groves Progress to Expand Isotope Business
- Neutral Sentiment: Strong demand for reliable power from artificial-intelligence data centers remains a favorable industry backdrop. Google’s agreement with Constellation for 3.59 gigawatts of nuclear power highlights growing corporate interest, although the deal does not directly add revenue to Oklo. Nuclear ETFs in Spotlight as Google and Constellation Sign 3.6 GW Deal
- Negative Sentiment: Oklo is still a speculative, pre-commercial company. It recently reported a quarterly adjusted loss of $0.28 per share versus an expected $0.16 loss, and analysts expect a full-year loss. The company’s small revenue base and need to execute on reactor and isotope projects continue to weigh on investor confidence.
- Negative Sentiment: The broader nuclear-stock retreat has also pressured OKLO alongside NuScale and Centrus. Commentary highlighting Oklo’s sharp longer-term share-price decline reinforces concerns about valuation, volatility and the time required to convert partnerships and development projects into cash flow. Nuclear Names Retreat
Analysts Set New Price Targets
A number of equities research analysts have commented on OKLO shares. Citigroup reduced their price target on Oklo from $76.00 to $57.50 and set a “neutral” rating on the stock in a research report on Monday, August 10th. UBS Group lowered their price objective on Oklo from $55.00 to $41.00 and set a “neutral” rating for the company in a research report on Friday, September 25th. Piper Sandler restated an “overweight” rating on shares of Oklo in a research report on Thursday, October 1st. Canaccord Genuity Group cut their price objective on Oklo from $125.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, August 10th. Finally, Guggenheim initiated coverage on Oklo in a report on Thursday, June 25th. They issued a “neutral” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Oklo presently has an average rating of “Moderate Buy” and an average target price of $82.44.
View Our Latest Analysis on OKLO
Oklo Company Profile
Oklo Inc is an advanced fission technology company developing compact nuclear power plants designed to provide reliable, carbon-free electricity. Its flagship Aurora powerhouse is a small-scale fission system intended to operate for extended periods and supply power directly to industrial, commercial, and other large energy users.
The company is also developing fuel-recycling capabilities to support the use of recovered nuclear fuel in advanced reactors. Oklo has pursued partnerships and regulatory work in the United States, including activities associated with the Idaho National Laboratory, and is initially focused on serving U.S.
Further Reading
- Five stocks we like better than Oklo
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Oklo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oklo and related companies with MarketBeat.com's FREE daily email newsletter.
